Bruce R. Campell

Array ( [id] => 18231543 [patent_doc_number] => RE049443 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2023-03-07 [patent_title] => Process for producing a stable low concentration, injectable solution of noradrenaline [patent_app_type] => reissue [patent_app_number] => 17/006838 [patent_app_country] => US [patent_app_date] => 2020-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3661 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17006838 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17920922 [patent_doc_number] => RE049238 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2022-10-11 [patent_title] => Alleviating oxidative stress disorders with PUFA derivatives [patent_app_type] => reissue [patent_app_number] => 16/997692 [patent_app_country] => US [patent_app_date] => 2020-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 12 [patent_no_of_words] => 16836 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16997692 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16555783 [patent_doc_number] => 20210000931 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-07 [patent_title] => COMPOSITIONS AND METHODS OF USE FOR ALPHA-1 ANTITRYPSIN HAVING NO SIGNIFICANT SERINE PROTEASE INHIBITOR ACTIVITY [patent_app_type] => utility [patent_app_number] => 16/855957 [patent_app_country] => US [patent_app_date] => 2020-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31677 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16855957 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18011482 [patent_doc_number] => RE049304 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2022-11-22 [patent_title] => Compositions and method for multiplex biomarker profiling [patent_app_type] => reissue [patent_app_number] => 16/840107 [patent_app_country] => US [patent_app_date] => 2020-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 47 [patent_no_of_words] => 39176 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 151 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16840107 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17996069 [patent_doc_number] => RE049294 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2022-11-15 [patent_title] => DNA vector production system [patent_app_type] => reissue [patent_app_number] => 16/810504 [patent_app_country] => US [patent_app_date] => 2020-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 9 [patent_no_of_words] => 13185 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16810504 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17903718 [patent_doc_number] => RE049229 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2022-10-04 [patent_title] => Methods and compositions for treating malignant tumors associated with KRAS mutation [patent_app_type] => reissue [patent_app_number] => 16/804696 [patent_app_country] => US [patent_app_date] => 2020-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 17528 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16804696 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18027181 [patent_doc_number] => RE049311 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2022-11-29 [patent_title] => None [patent_app_type] => reissue [patent_app_number] => 16/749275 [patent_app_country] => US [patent_app_date] => 2020-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 29906 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16749275 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17539239 [patent_doc_number] => RE049037 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2022-04-19 [patent_title] => Broadly neutralizing antibody and uses thereof [patent_app_type] => reissue [patent_app_number] => 16/726453 [patent_app_country] => US [patent_app_date] => 2019-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 13 [patent_no_of_words] => 19912 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16726453 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17539237 [patent_doc_number] => RE049035 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2022-04-19 [patent_title] => Traditional Chinese medicine composition, and preparation and application thereof [patent_app_type] => reissue [patent_app_number] => 16/715485 [patent_app_country] => US [patent_app_date] => 2019-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 22 [patent_no_of_words] => 17453 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16715485 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17554302 [patent_doc_number] => RE049050 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2022-04-26 [patent_title] => Traditional Chinese medicine composition, and preparation and application thereof [patent_app_type] => reissue [patent_app_number] => 16/713533 [patent_app_country] => US [patent_app_date] => 2019-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 22 [patent_no_of_words] => 18423 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16713533 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17973710 [patent_doc_number] => RE049281 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2022-11-08 [patent_title] => Wnt pathway stimulation in reprogramming somatic cells with nuclear reprogramming factors [patent_app_type] => reissue [patent_app_number] => 16/713457 [patent_app_country] => US [patent_app_date] => 2019-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 30403 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16713457 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17191467 [patent_doc_number] => RE048801 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2021-11-02 [patent_title] => Inhibition of a lncRNA for treatment of melanoma [patent_app_type] => reissue [patent_app_number] => 16/689648 [patent_app_country] => US [patent_app_date] => 2019-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 34 [patent_no_of_words] => 9276 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16689648 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17857909 [patent_doc_number] => RE049207 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2022-09-13 [patent_title] => Transposase-random priming DNA sample preparation [patent_app_type] => reissue [patent_app_number] => 16/678868 [patent_app_country] => US [patent_app_date] => 2019-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 10712 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 145 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16678868 [rel_patent_id] =>[rel_patent_doc_number] =>)